<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press &#8211; PROSOL</title>
	<atom:link href="https://www.prosol.it/tag/press/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.prosol.it</link>
	<description>Prosol</description>
	<lastBuildDate>Thu, 26 Aug 2021 10:56:59 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>Prosol Interview with Feedinfo: “Demedicalising Trend Boosts Yeast’s Prospects”</title>
		<link>https://www.prosol.it/in-the-press/prosol-interview-with-feedinfo-demedicalising-trend-boosts-yeasts-prospects/</link>
					<comments>https://www.prosol.it/in-the-press/prosol-interview-with-feedinfo-demedicalising-trend-boosts-yeasts-prospects/#respond</comments>
		
		<dc:creator><![CDATA[Prosol]]></dc:creator>
		<pubDate>Mon, 19 Jul 2021 08:19:57 +0000</pubDate>
				<category><![CDATA[animal nutrition]]></category>
		<category><![CDATA[In the press]]></category>
		<category><![CDATA[Press]]></category>
		<category><![CDATA[prosol press]]></category>
		<guid isPermaLink="false">https://www.prosol.it/?p=9882</guid>

					<description><![CDATA[Prosol Interview with Feedinfo: “Demedicalising Trend Boosts Yeast’s Prospects”   Daniele Bonvicini, our Managing Director at Prosol, had a talk with Feedinfo about Yeast’s Prospects in the animal nutrition market. In this Feedinfo perspectives interview we discuss how yeast products are in a position to provide valide alternatives in animal nutrition programs. In  [...]]]></description>
										<content:encoded><![CDATA[<div class="fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling" style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;" ><div class="fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap" style="max-width:calc( 1170px + 0px );margin-left: calc(-0px / 2 );margin-right: calc(-0px / 2 );"><div class="fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column" style="--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:0px;--awb-margin-bottom-large:0px;--awb-spacing-left-large:0px;--awb-width-medium:100%;--awb-spacing-right-medium:0px;--awb-spacing-left-medium:0px;--awb-width-small:100%;--awb-spacing-right-small:0px;--awb-spacing-left-small:0px;"><div class="fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column"><div class="fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-four"><h4 class="fusion-title-heading title-heading-left fusion-responsive-typography-calculated" style="margin:0;--fontSize:24;line-height:1.3;">Prosol Interview with Feedinfo: “Demedicalising Trend Boosts Yeast’s Prospects”</h4></div><div class="fusion-separator fusion-full-width-sep" style="align-self: center;margin-left: auto;margin-right: auto;margin-bottom:20px;width:100%;"><div class="fusion-separator-border sep-single sep-solid" style="--awb-height:20px;--awb-amount:20px;--awb-sep-color:#00904a;border-color:#00904a;border-top-width:1px;"></div></div><div class="fusion-text fusion-text-1"><p><em><img fetchpriority="high" decoding="async" class="wp-image-9886 alignright" src="http://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1.jpg" alt="" width="518" height="264" srcset="https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1-200x102.jpg 200w, https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1-300x153.jpg 300w, https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1-400x204.jpg 400w, https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1-600x306.jpg 600w, https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1-768x392.jpg 768w, https://www.prosol.it/wp-content/uploads/2021/07/1626100801324-1.jpg 784w" sizes="(max-width: 518px) 100vw, 518px" /></em><strong>Daniele Bonvicini</strong>, our Managing Director at <strong>Prosol</strong>, had a talk with <strong>Feedinfo</strong> about <em>Yeast’s Prospects</em> in the animal nutrition market. In this Feedinfo perspectives interview we discuss how yeast products are in a position to provide valide alternatives in animal nutrition programs.</p>
<p>In today’s conversation, in particular, Prosol unpacks the mode of action of the company’s yeasts and yeast derivatives and the recent research done around their efficacy in animal nutrition.</p>
<p>Click <a href="https://www.feedinfo.com/our-content/prosol-pushes-into-asia-as-demedicaAlising-trend-boosts-yeast-s-prospects-industry-perspectives/241764?utm_source=organic_social&amp;utm_medium=linkedin&amp;utm_campaign=PROSOL_BIOSPRINT_perspectives">here</a> to check the interview!</p>
</div><div class="fusion-separator fusion-full-width-sep" style="align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:20px;width:100%;"></div></div></div></div></div>
]]></content:encoded>
					
					<wfw:commentRss>https://www.prosol.it/in-the-press/prosol-interview-with-feedinfo-demedicalising-trend-boosts-yeasts-prospects/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
